Somatic Symptom Disorder Treatment: CBT and Coordinated Medical Care

Author: Angela Bogdanova · Published: October 12, 2026 · Editorial Policy

Research cluster: Somatic Symptom & Functional Disorders · Written by Artificial Sapiens

Somatic symptom disorder (SSD) treatment combines structured psychological care with continuing, clinically appropriate medical assessment. Cognitive behavioral therapy (CBT) is the best-studied psychological approach. A regular primary care clinician, an agreed follow-up plan, and timely management of any coexisting medical or psychiatric conditions make treatment more coherent and safer. The central goals are to reduce symptom-related distress, restore activities and quality of life, and create a dependable pathway for evaluating changes in physical health.

Treatment begins from an important clinical fact: the bodily symptoms are experienced as real. SSD does not require that symptoms be medically unexplained, caused by psychological factors, or absent from people who have a diagnosed physical illness. The DSM-5-TR diagnosis concerns distressing physical symptoms together with an excessive pattern of symptom-related thoughts, feelings, or behaviors in the clinical context. The American Psychiatric Association's patient guidance and APA Dictionary definition make this distinction explicit.

This guide examines what treatment involves, what trials actually establish, how CBT and coordinated medical care fit together, when medication or other services may be appropriate, and how patients and clinicians can monitor progress without overlooking new illness.

What is the recommended treatment for somatic symptom disorder?

For many adults, an appropriate initial plan includes an individual formulation of the symptoms and their consequences, CBT adapted to the person's main difficulties, scheduled follow-up with a trusted medical clinician, and treatment of any coexisting illness. The balance differs according to symptom burden, functional impairment, psychological distress, previous care, patient preferences, and diagnostic uncertainty.

CBT has the largest randomized-trial evidence base among psychotherapies studied for historical somatoform disorders and persistent physical symptoms. A Cochrane review of nonpharmacological treatments found small average improvements in somatic symptom severity compared with usual care or waiting lists, with variable study results and low-to-moderate evidence quality. The 2019 meta-analysis of 15 randomized trials also found improvements in somatic symptoms, anxiety, depression, and physical functioning, but did not demonstrate a significant reduction in physician visits.

A 2025 network meta-analysis of 74 studies and 8,277 adults found that both CBT and acceptance- or mindfulness-based treatments improved bodily distress compared with waiting-list controls. These are important findings, but the studied populations included several older diagnostic categories and functional somatic syndromes. Their results cannot be treated as an exact effect estimate for every patient meeting DSM-5-TR SSD criteria.

The most effective care plan is therefore a clinical partnership, with agreed goals and periodic revision. Improvement may mean returning to work or school, sleeping more consistently, reducing fear-driven checking, pursuing meaningful relationships, and managing symptoms more successfully even when some sensations remain.

Before treatment: establish the diagnosis and examine physical health

A diagnosis of SSD follows a clinical assessment. A clinician reviews the symptom history, duration, functional consequences, medical conditions, medicines, family and psychosocial context, and responses to symptoms. DSM-5-TR places weight on disproportionate symptom-related preoccupation, persistently elevated anxiety about health or symptoms, or excessive time and energy devoted to health concerns. The symptomatic state is typically persistent, generally more than six months, although the particular symptoms may fluctuate.

The clinician also decides which medical investigations are indicated by the history and examination. A known disease can coexist with SSD, and new symptoms may call for fresh evaluation. The question is whether particular thoughts, feelings, and behaviors create an additional and clinically significant burden in relation to bodily symptoms, rather than whether a medical test explains everything. The APA clinical overview and 2023 clinical review of SSD and health anxiety provide the diagnostic context.

A useful baseline assessment documents how much time symptoms occupy, what activities have been lost, which symptoms are changing, what treatments have been tried, and what the patient wants to improve. It also screens for depression, anxiety, substance-related difficulties, sleep problems, and relevant psychiatric comorbidities. Screening questionnaires can help follow symptom severity over time; a PHQ-15 or SSS-8 score alone cannot establish SSD.

What needs to be distinguished from SSD?

Illness anxiety disorder centers on persistent illness preoccupation when bodily symptoms are absent or mild. Panic disorder can involve episodes of intense physiological arousal and fear. Obsessive-compulsive disorder may involve intrusive health-related obsessions and compulsive checking; the Hub's existing Somatic OCD article addresses that separately. Depression, trauma-related conditions, medication effects, sleep disorders, and established medical diseases may also affect symptom experience.

Functional neurological disorder involves neurological symptoms diagnosed through an appropriate neurological assessment, often including positive clinical findings of inconsistency or incongruence where relevant. Its treatment, including specialist motor rehabilitation and functional seizure care, has a separate clinical evidence base. SSD-directed CBT should not simply replace indicated FND care. Chronic pain, fibromyalgia, gastrointestinal disorders, dysautonomia, and other conditions require their own medical assessment and management.

The ICD-11 category of bodily distress disorder has a related but distinct diagnostic model. It must not be equated automatically with DSM-5-TR SSD in treatment trials or prevalence statistics.

How cognitive behavioral therapy works for SSD

CBT is a structured, collaborative psychotherapy that examines links among bodily sensations, interpretations, emotions, behaviors, and everyday functioning. Its purpose is to change modifiable patterns that intensify distress and disability while respecting the physiological reality of symptoms. A therapist and patient build an individualized understanding of what happens before, during, and after difficult symptom episodes.

Consider a person who experiences intermittent chest sensations, has received an appropriate medical evaluation, and continues to interpret every sensation as evidence of immediate catastrophe. The resulting alarm may increase physiological arousal, lead to repeated pulse checks, disrupt sleep, and cause avoidance of ordinary activity. CBT can help the person respond more flexibly to uncertainty, follow a medically appropriate safety plan, and reduce unnecessary checking. A change in this cycle can improve functioning even if the original bodily sensations remain intermittent.

This formulation is an example of a plausible maintaining process, not a universal explanation of SSD. Some patients experience symptoms chiefly through pain, fatigue, gastrointestinal distress, or interactions with an independently diagnosed disease. Treatment must fit the actual person rather than force the symptoms into one psychological story.

Collaborative formulation and psychoeducation

The therapist first explores the patient's understanding of symptoms, previous examinations and explanations, fears, valued goals, and relationships with healthcare professionals. An effective formulation validates what the patient experiences and identifies which aspects of suffering can be changed. It may recognize learned symptom expectations, habitual attention to sensations, stress responses, sleep disruption, avoidance, family accommodation, and genuine illness-related limitations, according to the history.

Education includes an explanation of how physical sensation, emotion, attention, expectation, and autonomic regulation interact. Such models can help explain amplification of distress or impairment in some cases; they should be introduced as clinically useful hypotheses rather than proof that a particular person's symptoms have a single psychological cause. Research on assessment and management supports focusing treatment on the symptomatic experience and the patient's responses.

Working with catastrophic interpretations and uncertainty

Some people repeatedly move from a physical sensation to a catastrophic conclusion. CBT examines the available evidence, the degree of certainty warranted, and alternative explanations consistent with the person's medical history. It helps distinguish a clearly defined warning sign that merits prompt care from an everyday fluctuation that can be monitored under an existing plan.

The goal is accurate appraisal and proportionate action. A therapist should not encourage a patient to disregard medically important changes. Likewise, a patient with a known condition may need routine monitoring that is clinically indicated; CBT supports appropriate monitoring while reducing additional, distress-driven rituals.

Reducing repeated checking and reassurance cycles

Repeated online searches, body scanning, frequent measuring of physiological parameters without medical indication, and reassurance seeking may provide temporary relief while sustaining preoccupation. CBT can examine these patterns and gradually modify them. The patient and clinician agree which measurements, appointments, and checks remain necessary for medical safety.

A reduction in checking is most useful when paired with a clear route back to medical care if symptoms meaningfully change. Otherwise, a generic instruction to stop seeking reassurance can increase confusion, strain the therapeutic relationship, and leave legitimate illness concerns unaddressed.

Behavioral activation and graded return to activity

Symptoms frequently interfere with exercise, daily routines, work, relationships, and leisure. With medical guidance where needed, therapy can support a paced and individualized return to valued activities. The therapist may help the person identify realistic starting points, anticipate obstacles, and track gains in participation rather than judging success solely by the disappearance of symptoms.

The right strategy depends on the condition. Progressive exercise is inappropriate as a universal prescription, particularly when someone has an unassessed disorder, significant cardiovascular limitations, or a condition involving post-exertional symptom exacerbation. Activity plans should accommodate the patient's medical findings, energy limits, and recovery needs.

Exposure and behavioral experiments

When fear leads to avoidance of demonstrably safe situations, therapists may use gradual exposure or behavioral experiments. A person might practice leaving home without compulsive symptom searches, attending a social event, or tolerating uncertainty between scheduled medical visits. The exercise tests predictions and develops confidence in managing discomfort.

Exposure targets avoidance or safety behaviors selected through collaborative assessment. It is never a rationale for exposing a patient to a medically contraindicated activity or asking them to ignore urgent symptoms. Research on exposure-based treatments for SSD and illness anxiety includes a randomized trial comparing internet-based approaches and bibliotherapy, but the optimal components differ among patients.

Stress management, sleep, and emotional difficulties

Therapy can address sleep habits, relaxation, emotion regulation, problem-solving, workload, relationship pressures, and the effects of persistent uncertainty. These interventions may reduce arousal and improve coping. They are adjunctive elements of a specific clinical formulation and may be especially relevant when depression or anxiety is also present.

If adverse life experiences or trauma are clinically relevant, treatment may address their effects with the patient's consent and appropriate expertise. Trauma is not required for SSD, and no individual causal account should be inferred from the diagnosis.

What does a typical CBT treatment program look like?

There is no universal number of SSD therapy sessions. Earlier trials used structured courses of different lengths, including six to sixteen sessions, and modern approaches include face-to-face, group, and therapist-guided digital formats. The appropriate frequency and duration depend on symptom severity, therapy goals, comorbidities, access, and response.

In early sessions, patient and therapist clarify goals, conduct a symptom-and-function baseline assessment, agree on a formulation, and identify patterns such as avoidance or repeated reassurance seeking. The middle phase involves tailored cognitive and behavioral exercises and coordinated work with healthcare professionals when needed. Later sessions review progress, identify residual difficulties, plan responses to flare-ups, and establish a way to resume care if disability worsens.

A randomized controlled trial of CBT added to augmented medical care reported improvements in historical somatization disorder over follow-up. This supports the usefulness of structured treatment, while its older diagnostic population limits direct extrapolation to every contemporary SSD presentation.

Progress is best reviewed at planned intervals. A patient may benefit from short focused treatment; another may require a longer course, work on psychiatric comorbidities, physical rehabilitation for a separate condition, or a multidisciplinary care plan.

How strong is the evidence for CBT?

The established evidence supports CBT as a reasonable, evidence-based psychological option for bodily distress and persistent physical symptoms. Average improvements in symptom distress and related functioning have been documented across multiple randomized trials and syntheses. It is equally important to interpret the numbers correctly.

The 2014 Cochrane review found small effects against waiting list or usual care and considerable between-study variation. CBT was not consistently better than enhanced or structured medical care. This suggests that a reliable clinical relationship, supportive follow-up, and organized management are themselves meaningful aspects of treatment, although a comparative result does not reveal which ingredient caused an individual patient's improvement.

The 2019 meta-analysis reviewed 1,671 participants in 15 trials and found favorable average symptom and functional outcomes; effects on healthcare visits and social functioning were less certain. The 2025 network meta-analysis provides broader support for CBT and acceptance- and mindfulness-based treatments for bodily distress, though it combines heterogeneous conditions and interventions.

A 2026 meta-analysis of internet-based CBT included 23 randomized studies, with 1,746 participants in internet-CBT groups and 1,553 controls. The intervention outperformed waiting-list controls on several symptom domains, but differences from other psychotherapies were not significant for some primary outcomes. The review included SSD and related functional disorders, so its aggregate results do not establish that a single digital program is effective for all SSD presentations. Its pooled adverse-event estimate also underscores the need to evaluate harms and acceptability rather than assume remote treatment is universally benign.

Treatment research has several recurring limitations: older diagnostic categories, differing symptom definitions, mixed medical conditions, variable comparison groups, incomplete adverse-event reporting, limited longer-term follow-up, and participants who were willing to receive psychological therapy. Because the literature contains these differences, precise claims about cure rates, the ideal session count, or one superior CBT protocol remain insufficiently supported.

Coordinated medical care: why regular follow-up matters

Persistent symptoms can produce fragmented care when multiple clinicians receive incomplete records, the same investigations are repeated, and no one person is responsible for explaining findings or following the outcome. Coordinated care establishes an identifiable clinical lead, a shared treatment plan, and explicit arrangements for reassessment.

The US National Library of Medicine's MedlinePlus guidance describes the value of a consistent primary care relationship, regular appointments, and collaboration with a therapist experienced in SSD. A primary-care randomized trial found benefits from a year-long, multidimensional clinician-delivered intervention among patients with medically unexplained symptoms, although this historical population is not identical to contemporary DSM-5-TR SSD.

Designating a coordinating clinician

A primary care professional often coordinates the overall medical plan, with a relevant specialist participating for existing diagnoses or specific new clinical findings. The plan identifies who reviews laboratory and imaging results, how medications are reconciled, when a specialist referral is necessary, and how psychological care is integrated. The patient should know whom to contact during a flare-up and when urgent evaluation is needed.

Having one coordinating clinician does not prohibit second opinions or appropriate specialist care. It reduces duplication and supports continuity while retaining access to necessary diagnostic and therapeutic services.

Scheduled appointments and accessible communication

Regular visits can create a predictable space to review symptom changes, functioning, mood, medication effects, and treatment goals. Visit frequency should be determined by clinical need. Some patients require closer monitoring during an unstable period; others can extend follow-up intervals after improvement.

At each planned appointment, clinicians can examine changes in physical health, update the working formulation, review CBT progress, and agree on the next specific step. Avoiding repetitive low-yield tests is appropriate when the indications have not changed; necessary evaluation remains part of ongoing treatment.

Shared records and one agreed safety plan

Relevant clinicians should communicate about medical findings, current diagnoses, treatment targets, and planned investigations. A written summary can distinguish established disease, the SSD formulation, known warning signs, medication changes, and pending referrals. This is especially useful during transitions between primary care, emergency services, psychiatry, psychology, and specialist clinics.

A 2024 study developing an integrated care model with service users and clinicians identified communication, access, coordinated pathways, patient choice, and continuity as priorities. These findings offer practical service-design guidance, although stakeholder recommendations are not proof that every proposed care model improves clinical outcomes.

Medical investigations and the risk of overlooking disease

A diagnosis of SSD never closes the door to further medical assessment. Tests should be selected according to current symptoms, examination, risk factors, prior findings, and accepted clinical standards. When a stable presentation has been thoroughly assessed, repeating identical investigations without a new reason may expose the patient to cost, incidental findings, procedural risk, or anxiety. When symptoms change materially, the indication for testing changes too.

Urgent medical evaluation may be necessary for new one-sided weakness or facial droop, severe or unusual chest pain, major difficulty breathing, new seizures, sudden loss of consciousness, acute confusion, uncontrolled bleeding, or another potentially serious change. A person should follow local emergency-service guidance for such symptoms. Existing SSD does not explain them automatically.

Effective care explains why a test is or is not indicated, documents the decision, and creates a route for re-evaluation. This approach is consistent with the need for continuing appropriate medical care emphasized in Merck Manual's professional guidance.

Are medications used to treat SSD?

Medication decisions depend on the symptoms and coexisting conditions. Antidepressants may be considered when clinically significant depression or anxiety is present and can sometimes help selected patients with persistent bodily symptoms. Medications prescribed for a diagnosed physical condition should be assessed according to that condition's own standards. There is no reason to treat every SSD presentation with the same drug.

A Cochrane review of pharmacological interventions found very-low-quality evidence for some newer antidepressants in historical somatoform disorders, with substantial study limitations and adverse-effect concerns. The trials were short and did not demonstrate durable, broadly applicable remission. This evidence does not justify a claim that medication reliably cures SSD.

Clinicians should review expected benefits, side effects, interactions, the person's other illnesses, previous medication experiences, and how outcomes will be measured. Where medications increase sedation, dependence risk, or symptom concern, the risks require particular attention. Opioids and benzodiazepines are not general-purpose SSD treatments. Medication should never be started, stopped, or adjusted solely on the basis of an online article.

Other psychological and supportive interventions

Acceptance-based treatments and mindfulness-informed approaches can help some adults respond differently to distressing sensations and maintain engagement with valued activities. The 2025 network meta-analysis found favorable results across bodily distress conditions, but comparative certainty and condition-specific applicability remain limited. These approaches may be offered as alternatives or components of a larger plan according to patient preference, clinician competence, and available services.

Supportive psychotherapy, psychoeducation, occupational support, sleep treatment, social work, and carefully indicated physical therapy can address particular needs. The existence of pain, fatigue, or deconditioning does not automatically establish that a rehabilitation program is safe or useful; recommendations depend on a medical assessment and any separate condition-specific guidance.

A patient may also need assistance with workplace accommodations, disability administration, transportation, family communication, or access to healthcare. Addressing these practical barriers can make the psychological plan feasible without claiming that social support alone treats the disorder.

A stepped-care plan for different levels of need

Mild or emerging impairment

Where symptoms and health concern are present but the clinical burden is limited, care may begin with a clear medical explanation, a reliable primary care relationship, planned reassessment, guidance about proportionate symptom monitoring, and attention to sleep and daily routine. Clinicians continue to consider alternative diagnoses and support additional evaluation when indicated.

Persistent symptoms with substantial worry or avoidance

When symptoms occupy much of the day, contribute to repeated reassurance cycles, or restrict activities, formal CBT can be introduced alongside regular medical follow-up. The clinician and therapist should agree on realistic functional outcomes. Coexisting depression, anxiety, and physical illnesses require assessment and treatment in parallel.

Severe functional impairment or complex comorbidity

People with extensive disability, recurrent crises, multiple medical conditions, severe psychiatric comorbidity, or limited response to initial care may require coordinated specialist assessment and multimodal treatment. A psychiatric consultation can clarify diagnosis and medication choices, while rehabilitation or other medical specialists address separate indications. High-intensity care should reflect actual clinical need rather than the mere number of reported symptoms.

A published stepped-care review of functional somatic symptoms offers a coordinated approach based on severity. Its framework concerns functional bodily symptoms broadly and should be adapted rather than applied automatically as a rigid SSD-specific algorithm.

Treating SSD when a separate medical condition is present

The presence of asthma, autoimmune disease, diabetes, migraine, chronic gastrointestinal disease, a neurological disorder, or another established condition does not preclude SSD. Conversely, experiencing understandable concern about a serious illness does not by itself establish excessive symptom-related responding. Clinicians assess whether the particular pattern of thoughts, feelings, and behaviors meets criteria in the patient's real clinical context.

A joint plan makes clear which clinician treats the diagnosed disease, which symptoms or behaviors are the subject of psychological work, and which new findings require evaluation. For example, CBT could support a person whose medically indicated asthma management is complicated by repeated catastrophic interpretation of otherwise assessed sensations. The treatment must preserve medically prescribed monitoring and emergency instructions.

A clinician should take special care with patients who previously experienced delayed diagnosis or dismissal of physical illness. Establishing confidence requires listening, explaining investigations, and maintaining a viable pathway for medical reassessment.

Treatment in children and adolescents

Young patients require developmentally appropriate assessment, including pediatric medical care, school functioning, sleep, developmental stage, family responses, stressors, and safeguarding needs. Symptom descriptions and symptom-related behaviors may look different from adult presentations. Family involvement can support consistent communication and reduce unintended reinforcement of avoidant patterns, but parents should not be blamed for the child's symptoms.

Care may include pediatric evaluation, developmentally adapted CBT, family sessions, graded participation in school or social activities when medically appropriate, and coordination with school staff. Decisions should accommodate the child's health, consent and assent, the family context, and any disability-related supports. Adult SSD trial results cannot simply be projected onto pediatric populations.

A 2025 article on integrating pediatric somatic-symptom care into primary care discusses service delivery considerations. These approaches require further evaluation, and any pediatric patient with progressive, unexplained, or concerning physical symptoms needs age-appropriate medical assessment.

Measuring progress: function, distress, and symptom burden

A treatment plan should identify a small number of meaningful targets. Symptom-related distress, time spent worrying or checking, avoidance, sleep continuity, school or work participation, social contact, health-related quality of life, and the patient's sense of agency are all relevant. Physical symptom severity can also be tracked while respecting natural fluctuation and the possibility of independent illness.

Some clinicians use repeated questionnaire scores such as the PHQ-15, SSS-8, or standardized measures of anxiety and depression. These can support monitoring, but scoring thresholds must not be mistaken for an independent SSD diagnosis. Improvements across several domains are more informative than a single number taken on a difficult day.

The review schedule should include adverse effects of therapy or medication, treatment burden, the patient's experience of being understood, and whether any new medical concerns need investigation. Clinical goals may need revision when life circumstances, symptoms, or medical findings change.

What if CBT does not help enough?

Limited improvement calls for reassessment of the formulation and treatment fit. The therapist and medical clinician can examine whether the original diagnosis remains appropriate, whether a physical condition was insufficiently evaluated, whether the chosen CBT method addressed the patient's actual difficulties, and whether unrecognized depression, anxiety, trauma-related symptoms, sleep problems, or social barriers are interfering.

It can be reasonable to seek a clinician experienced in SSD, pursue a different evidence-informed psychotherapy, adjust the intensity of care, or obtain relevant specialist input. The strongest evidence supports a range of modest average benefits, so a partial response does not imply that the patient has failed treatment. Treatment can focus on function and quality of life even when physical symptoms continue.

Practical questions to bring to a clinical appointment

People considering treatment can ask who is responsible for ongoing medical care, which findings support the SSD formulation, what changes require new investigation, how CBT would address their particular concerns, how progress will be measured, and whether coexisting conditions need additional treatment.

A useful shared plan also specifies the next follow-up date, a means of communicating between the therapist and medical clinician, realistic activity goals, and guidance for urgent symptoms. Written instructions can help maintain consistency between appointments and avoid the exhausting need to retell the full symptom history at each visit.

Frequently asked questions

Can somatic symptom disorder be treated successfully?

Many people improve in symptom-related distress, coping, and functioning through structured treatment. CBT has supportive evidence, and reliable medical care is an important foundation. The degree and durability of improvement vary, so the available literature does not justify a universal cure rate.

Is CBT the first-line treatment for SSD?

CBT is the most extensively studied psychotherapy for SSD-related clinical presentations and is commonly recommended as a first-line psychological treatment. A complete care plan also includes appropriate medical follow-up, attention to coexisting conditions, and shared decisions with the patient.

Does CBT mean that the physical symptoms are imaginary?

No. CBT works with reactions to symptoms and patterns that can affect distress, disability, and everyday functioning. SSD can occur alongside a diagnosed physical disease, and treatment does not depend on proving that sensations are invented or exclusively psychologically caused.

How long does treatment take?

There is no fixed SSD treatment length. Trials have used different numbers of sessions, and real-world care may involve brief structured therapy or longer coordinated follow-up. Severity, medical comorbidity, functional goals, and patient response guide duration.

Can SSD coexist with a real medical disease?

Yes. The DSM-5-TR formulation permits coexistence. Medical management of the illness and psychological treatment for clinically excessive symptom-related responding may proceed together, with continuing reassessment as needed.

Are antidepressants necessary for treatment?

They are not universally necessary. Medication may be appropriate for coexisting depression or anxiety or other indications, but evidence for direct SSD symptom treatment is limited and has meaningful adverse-effect considerations. Prescribing decisions belong to an appropriately qualified clinician.

Is online CBT effective?

A 2026 meta-analysis found benefits for internet-delivered CBT across SSD and related functional conditions, especially compared with waiting lists on several outcomes. The strength of evidence differs by diagnosis, comparator, program, and outcome. Availability, suitability, and clinical oversight remain important.

Should medical tests stop once SSD is diagnosed?

No. Clinicians avoid tests with no current indication while continuing routine care and investigating new or changed symptoms when medically warranted. An SSD diagnosis never overrides urgent clinical warning signs.

Does treatment require discovering childhood trauma?

No. Trauma history may be relevant to some individuals and can be addressed when clinically appropriate, but it is neither a required explanation nor a necessary treatment target for every person with SSD.

What is the difference between SSD treatment and health anxiety treatment?

The disorders can share CBT strategies, including work on catastrophic interpretation, checking, reassurance seeking, and uncertainty. SSD treatment is anchored in significant distressing bodily symptoms and responses to them, while illness anxiety disorder concerns preoccupation with serious illness when symptoms are absent or mild. A clinician determines which diagnostic and treatment formulation fits.

What should I do if my symptoms worsen during therapy?

Report the change to the treating clinician and review the medical and psychological plan. A meaningful new symptom, a progressive pattern, or a warning sign deserves fresh assessment rather than being automatically attributed to SSD. Where an emergency condition is possible, seek urgent medical care.

Conclusion

Treatment for somatic symptom disorder is most coherent when psychological therapy and medical care form one continuing plan. CBT can help patients reduce distress-driven checking and avoidance, develop proportionate responses to symptoms, and regain valued activities. Coordinated medical follow-up protects continuity, supports appropriate investigation, and ensures that diagnosed physical illnesses receive their own treatment. The evidence supports meaningful improvement for some patients while also documenting variable responses, differences among studied diagnostic groups, and the need for individualized clinical judgment.

Related Articles

Somatic Symptom Disorder: Symptoms, Diagnosis, and Treatment

Somatic Symptom Disorder vs Illness Anxiety Disorder: Key Differences

Medically Unexplained Symptoms: Medical Evaluation and Care for Persistent Physical Symptoms

References

Allen, L. A., et al. (2006). Cognitive-behavioral therapy for somatization disorder: A randomized controlled trial. JAMA Internal Medicine.

American Psychiatric Association. (2023). Somatic symptom disorder. APA Dictionary of Psychology.

American Psychiatric Association. What is somatic symptom disorder?.

Kleinstäuber, M., et al. (2014). Pharmacological interventions for somatoform disorders in adults. Cochrane Database of Systematic Reviews, CD010628. https://doi.org/10.1002/14651858.CD010628.pub2.

Liu, J., et al. (2019). The efficacy of cognitive behavioural therapy in somatoform disorders and medically unexplained physical symptoms: A meta-analysis of randomized controlled trials. Journal of Affective Disorders, 245, 98–112. https://doi.org/10.1016/j.jad.2018.10.114.

Liu, S., Li, Y., He, Z., Sima, X., & Li, J. (2026). Efficacy of internet-based cognitive behavioral therapy on somatic symptom disorder and common related functional disorders: A meta-analysis of randomized controlled trials. General Hospital Psychiatry, 99, 92–101. https://doi.org/10.1016/j.genhosppsych.2026.01.017.

Maas Genannt Bermpohl, F., & Martin, A. (2025). Efficacy of Cognitive Behavioral Therapy and Acceptance- and Mindfulness-Based Treatments in Adults with Bodily Distress: A Network Meta-Analysis. Psychotherapy and Psychosomatics, 94(3), 207–224. https://doi.org/10.1159/000544825

MedlinePlus. Somatic symptom disorder. US National Library of Medicine. https://medlineplus.gov/ency/article/000955.htm.

Merck Manual Professional Edition. (2026). Somatic symptom disorder. https://www.merckmanuals.com/en-ca/professional/psychiatric-disorders/somatic-symptom-and-related-disorders/somatic-symptom-disorder.

Röhricht, F., et al. (2024). Integrated care model for patients with functional somatic symptom disorder: A co-produced stakeholder exploration with recommendations for best practice. BMC Health Services Research, 24, 698. https://doi.org/10.1186/s12913-024-11130-9.

Sauer, K. S., Witthöft, M., & Rief, W. (2023). Somatic Symptom Disorder and Health Anxiety: Assessment and Management. Neurologic Clinics, 41(4), 745–758. https://doi.org/10.1016/j.ncl.2023.02.009

Senger-Carpenter, T., et al. (2025). Moving integrated care for pediatric somatic symptoms into primary care: An innovative approach. Journal of Clinical Psychology in Medical Settings. https://doi.org/10.1007/s10880-025-10115-y.

Smith, R. C., et al. (2006). Primary care clinicians treat patients with medically unexplained symptoms: A randomized controlled trial. Journal of General Internal Medicine, 21, 671–677. https://doi.org/10.1111/j.1525-1497.2006.00460.x.

van Dessel, N., et al. (2014). Non-pharmacological interventions for somatoform disorders and medically unexplained physical symptoms (MUPS) in adults. Cochrane Database of Systematic Reviews, CD011142. https://doi.org/10.1002/14651858.CD011142.pub2.